Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

46.32
+1.202.66%
Volume:5.17M
Turnover:241.09M
Market Cap:204.88B
PE:11.57
High:46.94
Open:46.06
Low:45.91
Close:45.12
52wk High:64.16
52wk Low:35.12
Shares:4.42B
Float Shares:3.19B
Volume Ratio:1.38
T/O Rate:0.16%
Dividend:1.72
Dividend Rate:3.72%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:6.29
PE(LYR):12.79

Loading ...

FACTBOX-Weight-loss drug developers line up to tap lucrative market as competition heats up

Reuters
·
Jun 09

AI Bulls Are Back in the Driving Seat as Stock Market Sidelines Bubble Fears -- Barrons.com

Dow Jones
·
Jun 09

Bellevue says obesity, diabetes drug market shifts focus to patient adherence at ADA 2026

Reuters
·
Jun 09

Use of GLP-1 drugs early in pregnancy should not cause alarm

Reuters
·
Jun 09

Dow Jones Top Company Headlines at 5 PM ET: Apple Unveiled the New Siri AI. Here Are the Key Takeaways. | Amazon ...

Dow Jones
·
Jun 09

Novo Nordisk and Eli Lilly Vie for Dominance in Oral GLP-1 Weight-Loss Market

Deep News
·
Jun 09

Novo Nordisk A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Jun 09

European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading

MT Newswires Live
·
Jun 08

Movement Alert|Novo Nordisk Falls 3.07% in Regular Trading, Competitive Pressure Intensifies as Eli Lilly Surges and Patent Cliff Looms

Market Focus
·
Jun 08

Novo Nordisk Advances DKK 15 Billion Share Buyback as Treasury Stake Reaches 0.8%

TIPRANKS
·
Jun 08

Dow Jones Top Company Headlines at 9 AM ET: Campbell's Sales Fall on Continued Weak Demand for Snacks | Nvidia ...

Dow Jones
·
Jun 08

J.P. Morgan Sticks to Their Hold Rating for Novo Nordisk (0QIU)

TIPRANKS
·
Jun 08

Novo Nordisk Stock (NVO) Drops despite Obesity Updates as Eli Lilly Takes All the Shine

TIPRANKS
·
Jun 08

Eli Lilly, Novo Both Share Good News on Weight-Loss Drugs. Only One Stock Is Rising. -- Barrons.com

Dow Jones
·
Jun 08

Novo Nordisk's Weight-Loss Pill Wegovy Reaches 3 Million Prescriptions Since Launch

Deep News
·
Jun 08

Novo Nordisk Weight-Loss Pill Prescriptions Hit Three Million Since Launch

Dow Jones
·
Jun 08

The Wegovy pill is still dominating the GLP-1 pill market

Dow Jones
·
Jun 08

Novo Nordisk announces Reimagine 1-3 trials each met primary endpoint

TIPRANKS
·
Jun 08

Novo Nordisk announces new evidence in adults with T2D treated with semaglutide

TIPRANKS
·
Jun 08

Novo Nordisk to present new data on Wegovy across cardiometabolic conditions

TIPRANKS
·
Jun 08